🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This 2-part study will evaluate the effectiveness and side effects of two a...
Status
Completed
Location
National Institute of Dental And Craniofacial Research (NIDCR)
Start Date
1999-12
Trial ID
NCT00001955
Treatments Being Tested
That anti-TNF therapy and rituximab therapy are equally effective in treati...
Status
Completed
Location
NHS Fife
Start Date
2010-04
Trial ID
NCT01021735
Treatments Being Tested
The purpose of this study is to determine the optimal dosage of etanercept ...
Status
Completed
Location
Hospital Necker
Start Date
2013-10-01
Trial ID
NCT02030613
Treatments Being Tested
The investigators plan to measure the health of the vascular system of subj...
Status
Completed
Location
Emory University
Start Date
2010-08
Trial ID
NCT01989689
Treatments Being Tested
The primary aim of the study is to determine the safety and tolerability of...
Status
Completed
Location
Memory Assessment and Research Centre, Moorgreen Hospital
Start Date
2011-01
Trial ID
NCT01068353
Treatments Being Tested
The purpose of this study was to evaluate extended safety and efficacy of e...
Status
Completed
Location
Multiple Locations
Start Date
2002-04
Trial ID
NCT00356356
Treatments Being Tested
The purpose of this study is to determine if Enbrel® or Kineret® will have ...
Status
Completed
Location
Multiple Locations
Start Date
2002-09
Trial ID
NCT00121056
The primary objective of this study was to determine the efficacy of etaner...
Status
Terminated
Location
Multiple Locations
Start Date
2000-08-24
Trial ID
NCT03781375
Treatments Being Tested
Evaluate (i) safety of etanercept in patients with moderate to severe psori...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00581165
Treatments Being Tested
Enbrel was first approved as new medicine on 06 Oct 2003 in Korea and the i...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT01432249
Treatments Being Tested